Done sou Salè H1B

Akèy › Anplwayè › Massachusetts Eye and Ear Infirmary › Clinical Fellow

Clinical Fellow nan Massachusetts Eye and Ear Infirmary: Salè H-1B

19 aplikasyon kondisyon travay pou tit travay Clinical Fellow nan Massachusetts Eye and Ear Infirmary. Salè baz medyàn ofri $95,150; mwatye mitan $95,150–$100,733.

Demann (LCA)19
Salè medyan ofri$95,150
Mwatye salè yo$95,150–$100,733
10yèm–90yèm pousantaj$95,150–$106,612

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20232$94,575
FY20247$95,150
FY20256$97,075
FY20264$106,612

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$106,612
H-1B1 (Singapour)
Boston, MAMar 23, 2026Jul 11, 2026Certifye
$106,612
H-1B1 (Singapour)
Boston, MAMar 16, 2026Jul 11, 2026Certifye
$102,466Boston, MAJan 30, 2026Jul 1, 2026Certifye
$118,458Boston, MAJan 29, 2026Jul 1, 2026Certifye
$99,000Boston, MAApr 14, 2025Jul 1, 2025Certifye
$95,150
E-3
Boston, MAApr 4, 2025Jul 7, 2025Certifye
$95,150Boston, MAApr 4, 2025Jul 7, 2025Certifye
$95,150Boston, MAApr 4, 2025Jul 7, 2025Certifye
$99,000Boston, MAFeb 13, 2025Jul 12, 2025Certifye
$106,292–$110,000Boston, MAFeb 13, 2025Jul 1, 2025Certifye
$95,150Boston, MAMar 27, 2024Jul 1, 2024Certifye
$95,150Boston, MAFeb 13, 2024Jul 1, 2024Certifye
$95,150Boston, MAFeb 12, 2024Jul 1, 2024Certifye
$95,150Boston, MAFeb 9, 2024Jul 1, 2024Certifye
$99,000
E-3
Boston, MAFeb 6, 2024Jul 1, 2024Certifye
$99,000
H-1B1 (Singapour)
Boston, MAFeb 6, 2024Jul 15, 2024Certifye, apre retire
$95,150
Nivo II
Boston, MAFeb 1, 2024Jul 1, 2024Certifye
$95,150Boston, MAMay 1, 2023Jul 6, 2023Certifye
$94,000–$125,000Boston, MAMar 27, 2023Jul 8, 2023Certifye

Clinical Fellow nan tout anplwayè yo →

Lòt travay nan Massachusetts Eye and Ear Infirmary

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).